Onderzoeker
Eline Naert
- Trefwoorden:gynaecologische kanker
- Disciplines:Kankertherapie
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2019 → Heden
Publicaties
1 - 10 van 18
- Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort(2023)
Auteurs: Axel Van Damme, Julie Rombaut, Amin Makar, Emiel De Jaeghere, Eline Naert, Hannelore Denys, Philippe Tummers, Katrien Vandecasteele
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study(2023)
Auteurs: Emiel De Jaeghere, Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.
Pagina's: 475 - 491 - Tumor-infiltrating lymphocytes and PD-L1 expression in pleomorphic lobular breast carcinoma(2023)
Auteurs: Menekse GOKER, Stephanie Deblaere, Hannelore Denys, Glenn Vergauwen, Eline Naert, Rudy Van den Broecke
- Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial(2022)
Auteurs: Vincent Vakaet, Hans Vanhulle, Ingeborg Hilderson, Eline Naert, Wilfried De Neve, An Hendrix, Menekse GOKER, Herman Depypere, Glenn Vergauwen, Rudy Van den Broecke, et al.
Pagina's: 10 - 15 - 2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial(2022)Volume: 32
Auteurs: Emiel De Jaeghere, Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.
Pagina's: A187 - A188 - CHEK2 mutations and papillary thyroid cancer : correlation or coincidence?(2022)
Auteurs: Koen Kortbeek, Robin de Putter, Eline Naert
- Risk of thrombo-embolic events in ovarian cancer : does bevacizumab tilt the scale? A systematic review and meta-analysis(2021)
Auteurs: Micky Saerens, Emiel De Jaeghere, Nele Vandemaele, Hannelore Denys, Eline Naert
- Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma(2021)Volume: 32
Auteurs: Emiel De Jaeghere, Sandra Tuyaerts, Ann M.T. Van Nuffel, An Hendrix, P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, A. De Caluwe, et al.
Pagina's: S1449 - S1450 - Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer(2020)
Auteurs: Emiel De Jaeghere, Frederiek Laloo, Mieke Van Bockstal, Kathia De Man, Eline Naert, Philippe Tummers, Amin Makar, Pieter De Visschere, Frédéric Amant, Hannelore Denys
Pagina's: 335 - 343 - PRIMMO study protocol : a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer(2019)
Auteurs: Sandra Tuyaerts, An MT Van Nuffel, Eline Naert, Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, et al.